Literature DB >> 13563953

Studies of the mechanism of allergic eczematous contact dermatitis. II. Use of C14 labelled 2:4-dinitrochlorobenzene in guinea pigs.

V H WITTEN, C H MARCH.   

Abstract

Entities:  

Keywords:  DERMATITIS, CONTACT/experimental; NITROBENZENE/related compounds

Mesh:

Substances:

Year:  1958        PMID: 13563953     DOI: 10.1038/jid.1958.87

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  7 in total

1.  [RADIOACTIVE ISOTOPES IN DERMATOLOGICAL RESEARCH AND DIAGNOSIS].

Authors:  A WISKEMANN
Journal:  Arch Klin Exp Dermatol       Date:  1964-06-25

2.  Distribution of a contact sensitizer, 1-fluoro-2,4-dinitro-benzene, in the the tissues of the guinea-pig.

Authors:  A F Geczy; A Baumgarten
Journal:  Immunology       Date:  1972-03       Impact factor: 7.397

3.  DNP conjugates in guinea-pig lymph nodes during contact sensitization.

Authors:  D Parker; J L Turk
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

4.  [On the pathogenesis of contact eczema. 1. Autoradiographic distribution studies in the guinea pig following epicutaneous application of H3-dinitrochlorobenzene].

Authors:  W Thies; E Schwarz; G Palme
Journal:  Arch Klin Exp Dermatol       Date:  1965-12-16

5.  The distribution of antigen in flare up reaction in contact sensitivity to DNCB.

Authors:  S Fukushiro; S Nakagawa; M Gotoh; M Koshizawa; K Tanioku
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

6.  [The percutaneous absorption of trivalent and hexavalent chromium (Cr-51). On the pathogenesis of contact eczema].

Authors:  E SCHWARZ; H W SPIER
Journal:  Arch Klin Exp Dermatol       Date:  1960

7.  Studies on the sensitization of animals with simple chemical compounds. XI. The fate of labeled picryl chloride and dinitrochlorobenzene after sensitizing injections.

Authors:  E Macher; M W Chase
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.